Sign inJoin waitlistJoin the waitlist

Yousef Zakharia

Professor of Medicine · Mayo Clinic College of Medicine and Science

Credentials: · · · · · ·

History

Mayo Clinic College of Medicine and Science
Present

Hematology/Oncology Georgia Regents University
2016–2019
Hematology and Medical Oncology
Michigan State University
2013–2016
Internal Medicine
University of Rochester Medicine
2010–2013
Damascus University
2006–2010
Preliminary or Transitional Year
2005–2006
DAMASCUS UNIV, DAMASCUS
2001–2005

Research

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
New England Journal of Medicine · 2019 · 1,067 citations
Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
The Lancet Oncology · 2021 · 369 citations
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
New England Journal of Medicine · 2024 · 339 citations

Petros Grivas
23 papers
AA
Ajjai Alva
22 papers
Mohammed Milhem
22 papers
Mehmet Bilen
21 papers
Rana McKay
21 papers · 6 as a resident
Neeraj Agarwal
20 papers
Rohan Garje
20 papers · 11 as a fellow
Vadim Koshkin
20 papers
Ali Khaki
19 papers · 2 as a fellow
Monika Joshi
17 papers
Shilpa Gupta
16 papers
Umang Swami
16 papers · 10 as a fellow

Clinical trials

Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC)
Principal investigator · Completed · Phase 1
Yousef Zakharia
2019–2024
A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer
Principal investigator · Completed · Phase 1
Yousef Zakharia
2018–2024
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
Site PI · Recruiting · Phase 1, Phase 2
GlaxoSmithKline
2025–2028
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2018–2031